Abstract
Objective The Yale-Brown Obsessive Compulsive Scale Modified for Olfactory Reference Syndrome (ORS-YBOCS) is a self-rated measure for assessing the severity of current olfactory reference disorder (ORD) symptoms. This scale has been translated into multiple languages and used in previous studies. However, its psychometric properties have not been investigated. The present study aimed to develop a Japanese ORS-YBOCS (newly named the ORD-YBOCS) and examine its reliability and validity.
Methods A total of 104 individuals with self-reported ORD symptoms were included (mean age = 30.20 years, SD = 10.25). Internal consistency and factor structure were assessed by calculating Cronbach’s alpha and conducting confirmatory factor analysis (CFA) respectively. Convergent and divergent validity were examined via correlations with measures of Jikoshu-Kyofu symptoms, body image concerns, depression, and fear of negative evaluation.
Results The Japanese ORD-YBOCS had good internal consistency (α = .81) and acceptable construct validity (r = .43 with Jikoshu-Kyofu symptoms, r = .20 with body image concerns, r = .56 with depression, and r = .27 with fear of negative evaluation). The scree plot suggested a one-factor model, but the CFA results did not support this (CFI = 0.76, TLI = 0.70, RMSEA = 0.14, and SRMR = 0.10).
Conclusion This is the first study to examine the psychometric properties of the self-report ORS-YBOCS. The linguistically validated Japanese ORD-YBOCS showed good internal consistency and acceptable validity. These results suggest that the Japanese ORD-YBOCS is a valid and reliable tool to measure ORD symptom severity.
Competing Interest Statement
Ms. Sano has received a grant from the Tohoku University Fund by participating in a crowdfunding program. Dr. Greenberg has received research support from Koa Health and is a presenter for the Massachusetts General Hospital Psychiatry Academy in educational programs supported through independent medical education grants from pharmaceutical companies. She has received speaking honoraria from L Oreal and RBC Consultants (CeraVe Psychodermatology Advisory Board). Dr. Yoshida has no competing interests to declare.
Funding Statement
This work was supported by the Tohoku University Graduate School of Education.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Tohoku University Kawauchi-Minami Area Medical and Health Research Involving Human Participants Ethics Committee gave ethical approval for this work (2023-009) .
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
Data will be made available on request. The language of the data will be Japanese only.
